Moderate to severe chronic hand eczema research hub

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Abrocitinib in Subjects with Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

This study is looking at a new medicine called Cibinqo for people with long-lasting, moderate to severe hand eczema that hasn't improved with other treatments. It aims to see if the medicine is safe and effective in reducing symptoms.